vibrio

5 ms·

1.
by vibrio 7d ago
.
2.
by vibrio 8d ago
..or a crappy casino. (further precedents)
3.
by vibrio 8d ago
Circling the wagons and tending our own garden is a nice ideal, but is no panacea just because we build some factories in Cleveland, celebrate the end of Globalism , claim ‘US energy independence’ (that’s gotten quiet lately.) reassessing
4.
by vibrio 9d ago
What you say is all true. Put down that book and take a trip to a Corpus Christi Texas city council meeting (eg), and help get all that silly confusion sorted out.
5.
by vibrio 9d ago
Doh! (Switches on vpn)
6.
by vibrio 9d ago
I wish this was just an anecdote rather than an axiom.
7.
by vibrio 12d ago
Moon? I’m starting to wonder if there’s enough water for cities on earth.
8.
by vibrio 13d ago
Batttlezone was the tank game.
9.
by vibrio 17d ago
What are their data privacy and security policies? That is an important consideration.
10.
by vibrio 1mo ago
…and a trusted doctor isn’t necessarily a replacement for the CDC.
11.
by vibrio 2mo ago
Nice work! Love it.
12.
by vibrio 2mo ago
Wtf world do we live in that this sentence exists.
13.
by vibrio 2mo ago
To add a somewhat cynical view, a significant part of the original motivation for the ranibizumab (Lucentis) development was due to pricing arbitrage across diseases. bevicizumab was priced based on uses in cancer indications with a “large
14.
by vibrio 2mo ago
I agree with you that AAV is clearly a useful tool but at times the low levels of self discipline and scientific rigor that the field has applied to dosing is disappointing at best and scary at times. This includes use of other vector types
15.
by vibrio 3mo ago
I suspect there is a deep sequencing service that is non CLIA and cheap. True. they may not be trustworthy with the data. That said, there are steps here where the data is put into Claude. Do we trust that ?
16.
by vibrio 4mo ago
Maybe also an interesting case study in the inconsistent application of copyright law.
17.
by vibrio 4mo ago
I think their point is not the ESG component, but firms with traditionally irrational valuations (à la GameStop) for which index inclusion exceptions have been made to facilitate short term liquidity for IPO participants. Seems as though o
18.
by vibrio 4mo ago
I can’t wait until Thanksgiving.
19.
by vibrio 5mo ago
Just in that it’s not gonna work.
20.
by vibrio 6mo ago
…Better plan all day Better plan all week, better plan all month, better plan all year…. (Sorry, esoteric song lyric that applies.)
21.
by vibrio 7mo ago
Interesting analogy.
22.
by vibrio 7mo ago
This is interesting. As a naive user I’ve gotten the gut feeling of commoditization among the models. I assumed the data center capacity push is intended to be the differentiator but that still seems utility-like over time. (and the data
23.
by vibrio 7mo ago
(not intending ot be snarky, but this isn't my area of knowledge in the least.) Didn't the AI organizations 'get it both ways' when they trained on vast collection of works under copyright and then purely "own&#x27
24.
by vibrio 7mo ago
You've succinctly identified and communicated a real problem. In your opinion, what is the best approach, if any, to attempt to address it?
25.
by vibrio 8mo ago
Put this way, this seems reasonable. Beyond cell therapy, I don't thin the cost of drug is the motivation for not making it more freely available. 'Misuse' leading to potential liability or unjustified bad outcomes, along wi
26.
by vibrio 8mo ago
So charging patients/insurance companies at cost to fund the clinical studies?
27.
by vibrio 8mo ago
Not even cost plus? Not sure how that works, from the viewpoint of economic incentives.
28.
by vibrio 8mo ago
Knowing whether drugs work isn’t trivial. Patients are typically very heterogeneous in their responses to drugs. For example, pembrolizumab (the most successful cancer drug ever) typically only works in, say 30% of patients depending of th
29.
by vibrio 8mo ago
Cane you provide a list of the “stupid” drug approvals?
30.
by vibrio 9mo ago
lol. The battery life seems so short, I was starting to wonder whether this was the case...

More ›